Factors shown to contribute to the development of LMD from CNS metastasis include genomic alterations independent of primary tumor site in MAPK, CDH2, and SF3BI displaying significant gain-, loss- and switch-of-function mutations, respectively [27]. This evidence concerns the gene CDH2 and Langer mesomelic dysplasia.